The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson’s Disease
Biomarkers and disease-modifying therapies are both urgent unmet medical needs in the treatment of Parkinson’s disease (PD) and must be developed concurrently because of their interdependent relationship: biomarkers for the early detection of disease (i.e., prior to overt neurodegeneration) are nece...
| Huvudupphovsmän: | , , , |
|---|---|
| Materialtyp: | Artikel |
| Språk: | English |
| Publicerad: |
MDPI AG
2020-06-01
|
| Serie: | Biomolecules |
| Ämnen: | |
| Länkar: | https://www.mdpi.com/2218-273X/10/6/912 |